drugset / Trial / NCT03908580
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
NaSingle-groupOpen-labelTreatment
Summary
This study is "A Prospective, Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Treatment of Post Stroke Upper Limb Spasticity".
Timeline
- Start
- 2013-09-06
- Primary completion
- 2014-10-31
- Completion
- 2015-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meditoxin | Protein / enzyme biologic | 360 iu | Intramuscular |
Indications
No indication recorded.